Delivery Order 140D0426D0055-140D0426F0645

<p>The National Cancer Institute issued a $7,344 delivery order to Amvet Ritz JV LLC on June 5, 2026, under the 8(a) sole source set-aside for replacement of a Biospecimen Collection (BSC) system.</p> <p>Amvet Ritz JV LLC is an SBA-certified 8(a) joint venture. Place of performance is Bethesda, Maryland. The order is due for ultimate completion on September 5, 2026.</p>

<p>The National Cancer Institute issued a $10,581 delivery order to Amvet Ritz JV LLC, an SBA Certified 8(a) Joint Venture, on May 29, 2026, for carpentry modifications under an 8(a) sole source set-aside.</p> <p>Place of performance is Bethesda, Maryland. The order has a firm fixed price and an ultimate completion date of August 29, 2026.</p>

<p>The National Cancer Institute issued a $20,256 delivery order to Amvet Ritz JV LLC on May 22, 2026, under an 8(a) sole-source set-aside for small renovation work at the Bethesda, Maryland campus. The order carries a firm fixed price and an ultimate completion date of August 22, 2026. Place of performance is Bethesda, MD 20892.</p>

<p>The National Cancer Institute issued a delivery order to Amvet Ritz JV LLC on May 21, 2026, for electrical decommissioning with a ceiling value of $9,407.00 under an 8(a) sole source set-aside.</p> <p>Amvet Ritz JV LLC is an SBA Certified 8(a) Joint Venture. Place of performance is Bethesda, MD 20892. Work is due by August 21, 2026.</p>

<p>The National Cancer Institute issued a $20,718 delivery order to Amvet Ritz JV LLC on May 22, 2026, under an 8(a) sole-source set-aside for a biological fume hood.</p> <p>Amvet Ritz JV LLC is an SBA-certified 8(a) joint venture. Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of August 22, 2026.</p>

<p>The National Cancer Institute issued a $22,643 delivery order to Amvet Ritz JV LLC on June 4, 2026, under the 8(a) sole source set-aside. The order is for ice maker equipment with performance completion by September 4, 2026. Place of performance is Bethesda, MD.</p>

The National Cancer Institute issued a $21,735.68 delivery order to Olgoonik Federal, LLC on August 8, 2025, under an 8(a) sole-source set-aside. The order is identified as NCI-25-032 REPLACE BSC, with Change Order #02 issued subsequently. Ultimate completion is November 8, 2025. Place of performance is Bethesda, MD 20892. Olgoonik Federal, an Alaska Native Corporation-owned 8(a) program participant and small disadvantaged business, provides construction, facilities maintenance, and research...

<p>The National Cancer Institute issued a $16,670.61 delivery order to Scientific Consulting Group Inc., a woman-owned small business, on July 15, 2015, for a future cancer registry data linkages in-person meeting under a total small business set-aside.</p> <p>Place of performance is Bethesda, Maryland. The order, issued on a firm fixed price basis, has an ultimate completion date of April 18, 2020.</p>

<p>The National Cancer Institute issued a $68,006.40 delivery order to Astrix Technology LLC on June 18, 2019, under the General Services Administration's Scientific Equipment and Services (FSS-66) Multiple Award Schedule for professional scientific services.</p> <p>Place of performance is Red Bank, NJ. The order has a firm fixed price and an ultimate completion date of June 23, 2020. No set-aside was used.</p>

<p>The National Cancer Institute issued a delivery order to Astrix Technology LLC on November 12, 2019, under the GSA Multiple Award Schedule (Scientific Equipment and Services, FSS-66), with a ceiling value of $79,660.80.</p> <p>Place of performance is Bethesda, MD. The order is for professional services with an ultimate completion date of November 3, 2020, priced on a firm fixed-price basis. No set-aside was used.</p>